Canine CD34: cloning of the cDNA and evaluation of an antiserum to recombinant protein

Autor: FR Appelbaum, Richard A. Nash, George E. Sale, KA Rouleau, T de Revel, PM Wallace, Peter F Moore, L Krizanac-Bengez, Peter A. McSweeney, M Beauchamp, L. Bolles, B. M. Sandmaier, Rainer Storb

Publikováno v: Blood. 88:1992-2003

Increasingly, enriched populations of hematopoietic progenitors are used in experimental and clinical transplantation studies. The separation of progenitors is based on the expression of CD34, a marker preferentially expressed on progenitor cells. Th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d687e4b889b79197649d74d4b59419f6
https://doi.org/10.1182/blood.v88.6.1992.bloodjournal8861992

Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419).

Autor: Watterson SH; Bristol-Myers Squibb Pharmaceutical Research Institute, Post Office Box 4000, Princeton, New Jersey 08543, USA. scott.watterson@bms.com, Chen P, Zhao Y, Gu HH, Dhar TG, Xiao Z, Ballentine SK, Shen Z, Fleener CA, Rouleau KA, Obermeier M, Yang Z, McIntyre KW, Shuster DJ, Witmer M, Dambach D, Chao S, Mathur A, Chen BC, Barrish JC, Robl JA, Townsend R, Iwanowicz EJ

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2007 Jul 26; Vol. 50 (15), pp. 3730-42. Date of Electronic Publication: 2007 Jun 22.

Inhibitors of inosine monophosphate dehydrogenase: SARs about the N-[3-Methoxy-4-(5-oxazolyl)phenyl moiety.

Autor: Iwanowicz EJ; Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543-4000, USA. iwanowie@bms.com, Watterson SH, Guo J, Pitts WJ, Murali Dhar TG, Shen Z, Chen P, Gu HH, Fleener CA, Rouleau KA, Cheney DL, Townsend RM, Hollenbaugh DL

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2003 Jun 16; Vol. 13 (12), pp. 2059-63.

Identification of novel and potent isoquinoline aminooxazole-based IMPDH inhibitors.

Autor: Chen P; Discovery Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA. ping.chen@bms.com, Norris D, Haslow KD, Murali Dhar TG, Pitts WJ, Watterson SH, Cheney DL, Bassolino DA, Fleener CA, Rouleau KA, Hollenbaugh DL, Townsend RM, Barrish JC, Iwanowicz EJ

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2003 Apr 07; Vol. 13 (7), pp. 1345-8.

The TosMIC approach to 3-(oxazol-5-yl) indoles: application to the synthesis of indole-based IMPDH inhibitors.

Autor: Dhar TG; Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543-4000, USA. dharm@bms.com, Shen Z, Fleener CA, Rouleau KA, Barrish JC, Hollenbaugh DL, Iwanowicz EJ

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2002 Nov 18; Vol. 12 (22), pp. 3305-8.